Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 14 for ulcerative colitis

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

    Rochester, MN

  2. VE202 in Patients With Mild-to-Moderate Ulcerative Colitis

    Rochester, MN

  3. R-3750 in Patients With Mild to Moderate Ulcerative Colitis

    Rochester, MN

  4. Study of GS-5290 in Participants With Moderately-to-Severely Active Ulcerative Colitis

    Rochester, MN

  5. Phase 3 Program to Evaluate MK-7240 for Moderate to Severe Ulcerative Colitis

    Rochester, MN

  6. A Study of Vedolizumab in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

    Rochester, MN

  7. A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

    Rochester, MN

  8. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)

    Rochester, MN

  9. A 2-Part Phase 2 Study to Evaluate the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis

    Rochester, MN

  10. A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

    Rochester, MN

.

Mayo Clinic Footer